rs3765166

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003705.5(SLC25A12):​c.466-3C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.252 in 1,613,082 control chromosomes in the GnomAD database, including 55,169 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 4195 hom., cov: 32)
Exomes 𝑓: 0.26 ( 50974 hom. )

Consequence

SLC25A12
NM_003705.5 splice_region, intron

Scores

2
Splicing: ADA: 0.001212
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.360

Publications

14 publications found
Variant links:
Genes affected
SLC25A12 (HGNC:10982): (solute carrier family 25 member 12) This gene encodes a calcium-binding mitochondrial carrier protein. The encoded protein localizes to the mitochondria and is involved in the exchange of aspartate for glutamate across the inner mitochondrial membrane. Polymorphisms in this gene may be associated with autism, and mutations in this gene may also be a cause of global cerebral hypomyelination. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Apr 2012]
SLC25A12 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 39
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • mitochondrial disease
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 2-171837270-G-A is Benign according to our data. Variant chr2-171837270-G-A is described in ClinVar as Benign. ClinVar VariationId is 332344.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.555 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC25A12NM_003705.5 linkc.466-3C>T splice_region_variant, intron_variant Intron 5 of 17 ENST00000422440.7 NP_003696.2
SLC25A12NR_047549.2 linkn.380-3C>T splice_region_variant, intron_variant Intron 4 of 16
SLC25A12XM_047446142.1 linkc.193-3C>T splice_region_variant, intron_variant Intron 3 of 15 XP_047302098.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC25A12ENST00000422440.7 linkc.466-3C>T splice_region_variant, intron_variant Intron 5 of 17 1 NM_003705.5 ENSP00000388658.2
SLC25A12ENST00000263812.8 linkn.*86-3C>T splice_region_variant, intron_variant Intron 4 of 16 2 ENSP00000263812.4
SLC25A12ENST00000426896.5 linkn.570-3C>T splice_region_variant, intron_variant Intron 6 of 8 2 ENSP00000413968.1
SLC25A12ENST00000475360.6 linkn.*183-3C>T splice_region_variant, intron_variant Intron 7 of 7 5 ENSP00000437845.1

Frequencies

GnomAD3 genomes
AF:
0.214
AC:
32573
AN:
151976
Hom.:
4198
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.101
Gnomad AMI
AF:
0.145
Gnomad AMR
AF:
0.172
Gnomad ASJ
AF:
0.278
Gnomad EAS
AF:
0.573
Gnomad SAS
AF:
0.305
Gnomad FIN
AF:
0.268
Gnomad MID
AF:
0.229
Gnomad NFE
AF:
0.248
Gnomad OTH
AF:
0.222
GnomAD2 exomes
AF:
0.264
AC:
66341
AN:
251024
AF XY:
0.270
show subpopulations
Gnomad AFR exome
AF:
0.0981
Gnomad AMR exome
AF:
0.166
Gnomad ASJ exome
AF:
0.283
Gnomad EAS exome
AF:
0.575
Gnomad FIN exome
AF:
0.269
Gnomad NFE exome
AF:
0.254
Gnomad OTH exome
AF:
0.262
GnomAD4 exome
AF:
0.256
AC:
374156
AN:
1460988
Hom.:
50974
Cov.:
34
AF XY:
0.258
AC XY:
187549
AN XY:
726846
show subpopulations
African (AFR)
AF:
0.0916
AC:
3066
AN:
33462
American (AMR)
AF:
0.168
AC:
7503
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.285
AC:
7442
AN:
26130
East Asian (EAS)
AF:
0.562
AC:
22298
AN:
39684
South Asian (SAS)
AF:
0.306
AC:
26375
AN:
86240
European-Finnish (FIN)
AF:
0.273
AC:
14585
AN:
53378
Middle Eastern (MID)
AF:
0.250
AC:
1442
AN:
5760
European-Non Finnish (NFE)
AF:
0.248
AC:
275945
AN:
1111256
Other (OTH)
AF:
0.257
AC:
15500
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
13733
27467
41200
54934
68667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9360
18720
28080
37440
46800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.214
AC:
32554
AN:
152094
Hom.:
4195
Cov.:
32
AF XY:
0.218
AC XY:
16196
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.101
AC:
4174
AN:
41514
American (AMR)
AF:
0.172
AC:
2629
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.278
AC:
965
AN:
3470
East Asian (EAS)
AF:
0.572
AC:
2956
AN:
5164
South Asian (SAS)
AF:
0.305
AC:
1468
AN:
4820
European-Finnish (FIN)
AF:
0.268
AC:
2829
AN:
10568
Middle Eastern (MID)
AF:
0.226
AC:
66
AN:
292
European-Non Finnish (NFE)
AF:
0.248
AC:
16873
AN:
67956
Other (OTH)
AF:
0.219
AC:
462
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1213
2426
3640
4853
6066
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
356
712
1068
1424
1780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.241
Hom.:
21598
Bravo
AF:
0.204
Asia WGS
AF:
0.356
AC:
1241
AN:
3476
EpiCase
AF:
0.248
EpiControl
AF:
0.251

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 23, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
6.3
DANN
Benign
0.37
PhyloP100
0.36
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0012
dbscSNV1_RF
Benign
0.016
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3765166; hg19: chr2-172693780; COSMIC: COSV55536150; COSMIC: COSV55536150; API